Feed Articles

CVS is changing its strategy: Smaller stores, more emphasis on pharmacy services

CVS, one of the largest pharmacy chains in the US, has decided to change its strategy and focus on shrinking its stores. The move is part of a broader turnaround plan for the company, which is in a period of transformation. It will open about a dozen new stores this year that will be half the size of its traditional stores and focus only on pharmacy products, eliminating the traditional store front that typically offers candy, gift cards and other consumer goods.

Focus on pharmacies instead of retail

The reduction in store size is just one of the steps $CVS is taking to adapt to current industry changes. In addition to new smaller stores, the company plans to close more than 1,000 locations and lay off thousands of employees. The move is a response to the challenges facing drugstore chains like CVS, which have experienced intense competition from giants like Amazon, Target and Walmart in recent years, while also dealing with rising crime rates that have negatively impacted their profitability.

The smaller-sized stores will focus primarily on full-service pharmacy services and some commonly available products, a CVS spokesman said. "These stores will be designed to meet the specific needs of communities in the pharmacy industry," a company representative said. He said the goal is to tailor the size and assortment of the stores to the specific needs of local customers and improve the availability of pharmacy services in different geographic areas.

Challenges for traditional pharmacy chains

This trend shows that CVS is trying to focus its efforts on defending revenue from the pharmacy side of its business. Neil Saunders, an analyst at GlobalData Retail, pointed out that focusing only on pharmacies means that CVS has done "very little to defend the revenue from the retail side of its business." He said it is cheaper to run smaller stores that focus on core products, but this is not a complete solution for CVS as digital competitors and competition from chains such as Walmart continue to grow in the market.

The move is not unique, however. Other major drugstore chains are facing similar issues. Last week, for example, Walgreens Boots Alliance announced it was selling itself to a private equity firm in a deal worth $24 billion. The company thus shed its status as a publicly traded company after more than a century. In addition, even competitor Rite Aid recently went through bankruptcy and closed hundreds of stores.

Overall, then, the pharmacy sector is experiencing a period of change in which companies like CVS are struggling to adapt to new conditions and competition, which may mean not only changes in store size but also a fundamental rethinking of business strategies.

Disclaimer: You will find a lot of inspiration on Bulios, but stock selection and portfolio construction is up to you, so always conduct a thorough analysis of your own.

Source: CNN

Stocks mentioned

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

These 3 Stocks Raised Their Dividends During the 2008 Crisis and COVID. One Pays Every Month

When companies were canceling shareholder payouts in 2009 and again during the pandemic, these three railway companies were raising them instead. Today they offer yields of 2.1% to 5.7% a year.

MC
Milan Charvat
· 6h
Read more
BLACK

She designs drugs with AI, and Cathie Wood wanted her at $16. Today it's $14

An AI-designed cancer drug reached patients in two years. Its maker raised $172 million on the stock market, and funds linked to Cathie Wood and Druckenmiller wanted shares. Then the price fell 62% in three weeks.

KJ
Kryštof Jáně
· 10h
Read more
BLACK

Americans Have Stopped Buying on Credit. Which Stocks Will Take the Hit?

The monthly payment on a new car in the US has climbed to $823, and auto dealers' sales fell 1.6% in October. In the same week, Target reported its fastest sales growth in five years. Meanwhile, the market expects the Fed to make credit even more expensive in three weeks.

MC
Milan Charvat
· 11h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy